The LES USA-Canada 2023 Deals of Distinction award was won by Astellas Inc. and Cullgen for a strategic collaboration to develop therapies in various areas based on Targeted Protein Degradation pathway. The awardees will present the nature of the deal and key challenges, diligence and other aspects leading to the deal and collaboration.

Speakers:

• Seth Goldblum, Senior Vice President-Corporate Development, Cullgen
• Tomohiro Yamauchi, PhD, Head of Scouting & Transaction, Astellas Pharma, Inc.

Moderator: Booma Yandava, LES USA-Canada Life Sciences Sector Awards Chair